Drug Regulation

Generic Drug Use Synthetic Opioids Cannabis Legalization Access to Medications Legal Standards Psychedelic Substances Clinical Research Psychedelics Cannabis Legislation Patent Rights

10 ARTICLES

last mo.

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

The court said routine FDA-compliant labels and ordinary marketing do not by themselves prove inducement and set a higher bar requiring clear affirmative steps to encourage patented uses.

3 ARTICLES

11mo ago

Canadian Cannabis Potency Surge Tied to Rising Psychosis and Schizophrenia Risks